{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T17:01:10Z","timestamp":1776358870703,"version":"3.51.2"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Med Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Infectious diseases, particularly parasitic infections such as toxoplasmosis, contribute significantly to the morbidity and mortality of hemodialysis patients. <jats:italic>Toxoplasma gondii<\/jats:italic> infection poses serious risks, especially to immunocompromised individuals. This study aimed to assess the prevalence of latent toxoplasmosis in dialysis patients in Markazi Province, Iran.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A total of 181 patients (168 hemodialysis and 13 peritoneal dialysis) were included in this cross-sectional study. Blood samples were collected and tested for anti-Toxoplasma IgG and IgM antibodies using ELISA, while PCR was used to detect <jats:italic>T. gondii<\/jats:italic> DNA. Data were analyzed using SPSS, with P\u2009&lt;\u20090.05 considered significant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Out of 181 patients, 123 (67.95%) were seropositive for IgG antibodies, with the highest prevalence in those aged over 60\u00a0years. No cases tested positive for IgM antibodies or <jats:italic>T. gondii<\/jats:italic> DNA. Age was significantly associated with higher seroprevalence (P\u2009&lt;\u20090.05), but there were no significant differences regarding gender, dialysis type, or duration of dialysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The high prevalence of latent toxoplasmosis in dialysis patients underscores the need for regular screening to prevent serious complications. Given the limitations of serological tests, molecular diagnostics like PCR should be considered for better detection in immunocompromised patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41182-024-00676-3","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T07:53:37Z","timestamp":1736841217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sero-molecular prevalence of toxoplasmosis in hemodialysis and peritoneal dialysis patients in Markazi Province, Iran"],"prefix":"10.1186","volume":"53","author":[{"given":"Hossein","family":"Sarmadian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mana","family":"Shojapour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fereshteh","family":"chegeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Amin","family":"Tabatabaiefar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshid","family":"Haghverdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roham","family":"Sarmadian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Ghasemikhah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"issue":"12\u201313","key":"676_CR1","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","volume":"30","author":"AM Tenter","year":"2000","unstructured":"Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30(12\u201313):1217\u201358.","journal-title":"Int J Parasitol"},{"issue":"7","key":"676_CR2","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0020-7519(98)00023-X","volume":"28","author":"J Dubey","year":"1998","unstructured":"Dubey J. Advances in the life cycle of Toxoplasma gondii. Int J Parasitol. 1998;28(7):1019\u201324.","journal-title":"Int J Parasitol"},{"issue":"6","key":"676_CR3","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1128\/jcm.35.6.1411-1414.1997","volume":"35","author":"DK Howe","year":"1997","unstructured":"Howe DK, Honor\u00e9 S, Derouin F, Sibley LD. Determination of genotypes of toxoplasma gondii strains isolated from patients with toxoplasmosis. J Clin Microbiol. 1997;35(6):1411\u20134.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"676_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1017\/S0031182000064866","volume":"111","author":"Z Guo","year":"1995","unstructured":"Guo Z, Johnson A. Genetic characterization of Toxoplasma gondii strains by random amplified polymorphic DNA polymerase chain reaction. Parasitology. 1995;111(2):127\u201332.","journal-title":"Parasitology"},{"key":"676_CR5","first-page":"94","volume":"786","author":"M Dard\u00e9","year":"1992","unstructured":"Dard\u00e9 M, Bouteille B, Pestre-Alexandre M. Isoenzyme analysis of 35 Toxoplasma gondii isolates and the biological and epidemiological implications. J Parasitol. 1992;786:94.","journal-title":"J Parasitol"},{"issue":"10","key":"676_CR6","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1046\/j.1469-0691.2002.00485.x","volume":"8","author":"D Hill","year":"2002","unstructured":"Hill D, Dubey JP. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect. 2002;8(10):634\u201340.","journal-title":"Clin Microbiol Infect"},{"key":"676_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/B978-0-444-53490-3.00008-X","volume":"114","author":"SK Halonen","year":"2013","unstructured":"Halonen SK, Weiss LM. Toxoplasmosis. Handb Clin Neurol. 2013;114:125\u201345.","journal-title":"Handb Clin Neurol"},{"issue":"12","key":"676_CR8","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.3201\/eid2512.181565","volume":"25","author":"F Pinto-Ferreira","year":"2019","unstructured":"Pinto-Ferreira F, Caldart ET, Pasquali AKS, Mitsuka-Bregan\u00f3 R, Freire RL, Navarro IT. Patterns of transmission and sources of infection in outbreaks of human toxoplasmosis. Emerg Infect Dis. 2019;25(12):2177.","journal-title":"Emerg Infect Dis"},{"key":"676_CR9","first-page":"389","volume":"8","author":"ZD Wang","year":"2017","unstructured":"Wang ZD, Liu HH, Ma ZX, Ma HY, Li ZY, Yang ZB, et al. Toxoplasma gondii infection in immunocompromised patients: a systematic review and meta-analysis. Front Microbiol. 2017;8:389.","journal-title":"Front Microbiol"},{"issue":"6","key":"676_CR10","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3109\/0886022X.2016.1172940","volume":"38","author":"S Rasti","year":"2016","unstructured":"Rasti S, Hassanzadeh M, Soliemani A, Hooshyar H, Mousavi SG, Nikoueinejad H, Abdoli A. Serological and molecular survey of toxoplasmosis in renal transplant recipients and hemodialysis patients in Kashan and Qom regions, central Iran. Ren Fail. 2016;38(6):970\u20133.","journal-title":"Ren Fail"},{"issue":"2","key":"676_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12639-024-01667-1","volume":"48","author":"EF Fadel","year":"2024","unstructured":"Fadel EF, El-Hady HA, Ahmed AM, Tolba MEM. Molecular diagnosis of human toxoplasmosis: the state of the art. J Parasit Dis. 2024;48(2):201\u201316.","journal-title":"J Parasit Dis"},{"key":"676_CR12","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2018016","author":"M Foroutan","year":"2018","unstructured":"Foroutan M, Rostami A, Majidiani H, Riahi SM, Khazaei S, Badri M, Yousefi E. A systematic review and meta-analysis of the prevalence of toxoplasmosis in hemodialysis patients in Iran. Epidemiol Health. 2018. https:\/\/doi.org\/10.4178\/epih.e2018016.","journal-title":"Epidemiol Health"},{"issue":"1","key":"676_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s41182-020-00222-x","volume":"48","author":"M Mousavi-Hasanzadeh","year":"2020","unstructured":"Mousavi-Hasanzadeh M, Sarmadian H, Ghasemikhah R, Didehdar M, Shahdoust M, Maleki M, Taheri M. Evaluation of Toxoplasma gondii infection in western Iran: seroepidemiology and risk factors analysis. Trop Med Health. 2020;48(1):35.","journal-title":"Trop Med Health"},{"issue":"1","key":"676_CR14","first-page":"8251462","volume":"2023","author":"S Kadkhodaei","year":"2023","unstructured":"Kadkhodaei S, Jahromi ZK, Taghipour A, Rezanezhad H, Solhjoo K. A case-control seroprevalence survey of toxoplasmosis in hemodialysis patients and healthy subjects in Kazeroon and Jahrom Districts in Fars Province, Southern Iran. J Parasitol Res. 2023;2023(1):8251462.","journal-title":"J Parasitol Res"},{"issue":"1","key":"676_CR15","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1186\/s13104-020-05396-5","volume":"13","author":"S Soltani","year":"2020","unstructured":"Soltani S, Kahvaz MS, Soltani S, Maghsoudi F, Foroutan M. Seroprevalence and associated risk factors of Toxoplasma gondii infection in patients undergoing hemodialysis and healthy group. BMC Res Notes. 2020;13(1):551.","journal-title":"BMC Res Notes"},{"issue":"141","key":"676_CR16","first-page":"123","volume":"26","author":"MH Motazedian","year":"2016","unstructured":"Motazedian MH, Fouladvand M, Barazesh A. The prevalence of toxoplasmosis in hemodialysis patients in Bushehr, Iran in 2012. J Mazandaran Univ Med Sci. 2016;26(141):123\u201330.","journal-title":"J Mazandaran Univ Med Sci"},{"key":"676_CR17","doi-asserted-by":"publisher","DOI":"10.5812\/numonthly.40182","author":"SH Seyyedpour","year":"2016","unstructured":"Seyyedpour SH, Afshar P, Barzegarnejad A, Kalhori S, Agah R. Evaluation of anti-Toxoplasma gondii antibodies in hemodialysis patients with chronic kidney disease in Sari Iran. Nephro-Urol monthly. 2016. https:\/\/doi.org\/10.5812\/numonthly.40182.","journal-title":"Nephro-Urol monthly"},{"issue":"2","key":"676_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.15171\/npj.2017.13","volume":"6","author":"M Dorri","year":"2017","unstructured":"Dorri M, Dabirzadeh M, Maroufi Y, Afshari M, Chokamy MB. Prevalence of anti-Toxoplasma IgG and IgM in hemodialysis patients comparing to healthy individuals in Sistan area Iran. J Nephropharmacol. 2017;6(2):106\u20139.","journal-title":"J Nephropharmacol"},{"issue":"1","key":"676_CR19","first-page":"78","volume":"20","author":"SJ Seyyed Tabaei","year":"2018","unstructured":"Seyyed Tabaei SJ, Arab Mazar Z, Yadegarnia D, Rajaeian S, Fallahi S. Prevalence of the toxoplasma gondii IgM and IgG antibodies in hemodialysis patients in selected hemodialysis centers of Tehran city in 2016. Sci Magazine Yafte. 2018;20(1):78\u201384.","journal-title":"Sci Magazine Yafte"},{"issue":"4","key":"676_CR20","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cegh.2019.01.007","volume":"7","author":"N Arefkhah","year":"2019","unstructured":"Arefkhah N, Hosseini SA, Karimzade R, Moshfe A, Hadinia F, Abbasi Larki R, et al. Seroprevalence and risk factors of toxoplasma gondii infection among cancer and hemodialysis Patients in southwest Iran. Clin Epidemiol Global Health. 2019;7(4):596\u20139.","journal-title":"Clin Epidemiol Global Health"},{"issue":"4","key":"676_CR21","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/s11686-020-00238-7","volume":"65","author":"F Saadat","year":"2020","unstructured":"Saadat F, Mahmoudi MR, Rajabi E, Roshan ZA, Shad BM, Karanis P. Seroepidemiology and associated risk factors of toxoplasma gondii in hemodialysis patients. Acta Parasitol. 2020;65(4):906\u201312.","journal-title":"Acta Parasitol"},{"issue":"2","key":"676_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/parasitologia3020015","volume":"3","author":"MC Seck","year":"2023","unstructured":"Seck MC, Mbow M, Seck SM, Dia YA, Diallo I, Cisse M, et al. Seroepidemiology of toxoplasmosis in hemodialysis patients in senegal. Parasitologia. 2023;3(2):142\u201350.","journal-title":"Parasitologia"},{"key":"676_CR23","first-page":"1","volume":"15","author":"S Hussein","year":"2019","unstructured":"Hussein S, Molan A-L. Prevalence of toxoplasma gondii infection in hemodialysis patients with chronic renal failure and risk factors in Diyala province, Iraq. Malaysian J Med Health Sci. 2019;15:1.","journal-title":"Malaysian J Med Health Sci"},{"issue":"1","key":"676_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4274\/tpd.galenos.2022.87587","volume":"47","author":"\u015e Y\u00fcrekt\u00fcrk","year":"2023","unstructured":"Y\u00fcrekt\u00fcrk \u015e, Y\u0131lmaz H, Cengiz ZT. Investigation of anti-toxoplasma gondii Antibodies in the hemodialysis patients with ELISA method. Turkiye Parazitol Derg. 2023;47(1):16\u201321.","journal-title":"Turkiye Parazitol Derg"},{"issue":"6","key":"676_CR25","first-page":"197","volume":"10","author":"R Nahnoush","year":"2016","unstructured":"Nahnoush R, Youssif E, Hassanin O. Detection of toxoplasmosis in hemodialysis Egyptian patients using serological and molecular techniques. Aust J Basic Appl Sci. 2016;10(6):197\u2013201.","journal-title":"Aust J Basic Appl Sci"},{"issue":"2","key":"676_CR26","doi-asserted-by":"publisher","first-page":"551","DOI":"10.4269\/ajtmh.17-0677","volume":"98","author":"JL Jones","year":"2018","unstructured":"Jones JL, Kruszon-Moran D, Elder S, Rivera HN, Press C, Montoya JG, McQuillan GM. Toxoplasma gondii Infection in the United States, 2011\u20132014. Am J Trop Med Hyg. 2018;98(2):551\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"676_CR27","first-page":"21","volume":"16","author":"NL El-Tantawy","year":"2024","unstructured":"El-Tantawy NL. Toxoplasmosis seroprevalence among hemodialysis patients: a case-control study. Egypt Acad J Biol Sci E Med Entomol Parasitol. 2024;16(1):21\u20137.","journal-title":"Egypt Acad J Biol Sci E Med Entomol Parasitol"},{"issue":"8","key":"676_CR28","doi-asserted-by":"publisher","first-page":"621","DOI":"10.12980\/JCLM.3.2015J5-76","volume":"3","author":"F Hamidi","year":"2015","unstructured":"Hamidi F, Etemadi J, Ghabouli Mehrabani N, Mahami Oskouei M, Motavalli R, Ardalan MR. Comparison of Toxoplasma gondii seropositivity in hemodialysis and peritoneal dialysis patients. J Coast Life Med. 2015;3(8):621\u20132.","journal-title":"J Coast Life Med"},{"issue":"12","key":"676_CR29","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1080\/14787210.2021.1941867","volume":"19","author":"MG Robert","year":"2021","unstructured":"Robert MG, Brenier-Pinchart MP, Garnaud C, Fricker-Hidalgo H, Pelloux H. Molecular diagnosis of toxoplasmosis: recent advances and a look to the future. Expert Rev Anti Infect Ther. 2021;19(12):1529\u201342.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"676_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00472","author":"FHA Murata","year":"2020","unstructured":"Murata FHA, Previato M, Frederico FB, Barbosa AP, Nakashima F, Faria GMd, et al. Evaluation of serological and molecular tests used for the identification of toxoplasma Gondii infection in patients treated in an ophthalmology clinic of a public health service in S\u00e3o Paulo State Brazil. Front Cell Infect Microbiol. 2020. https:\/\/doi.org\/10.3389\/fcimb.2019.00472.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"676_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s41182-024-00585-5","volume":"52","author":"S Yarahmadi","year":"2024","unstructured":"Yarahmadi S, Saki J, Arjmand R, Shahbazian H. Toxoplasma gondii molecular detection and phylogenetic analysis in hemodialysis patients from Khuzestan, Southwest Iran. Trop Med Health. 2024;52(1):19.","journal-title":"Trop Med Health"},{"issue":"5","key":"676_CR32","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S2222-1808(15)61044-1","volume":"6","author":"B Rezavand","year":"2016","unstructured":"Rezavand B, Poornaki AM, Mokhtari KR, Mohammad A, Andalibian A, Abdi J. Identification and determination of the prevalence of Toxoplasma gondii in patients with chronic renal failure by ELISA and PCR. Asian Pacific J Trop Dis. 2016;6(5):347\u20139.","journal-title":"Asian Pacific J Trop Dis"},{"issue":"6","key":"676_CR33","first-page":"1239","volume":"56","author":"HM El-Askary\u02e1","year":"2025","unstructured":"El-Askary\u02e1 HM, El-Badry AA, Shaapan RM, Ismail MA, Ghieth MA, Sheemy S, M, et al. Toxoplasma antibodies, toxoplasma-DNA and antibodies of HCV and HIV in patients with hemodialysis in BENI-SUEF Egypt. Egypt J Veterinary Sci. 2025;56(6):1239\u201346.","journal-title":"Egypt J Veterinary Sci"},{"key":"676_CR34","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/s11686-020-00238-7","volume":"65","author":"F Saadat","year":"2020","unstructured":"Saadat F, Mahmoudi MR, Rajabi E, Roshan ZA, Shad BM, Karanis P. Seroepidemiology and associated risk factors of Toxoplasma gondii in hemodialysis patients. Acta Parasitol. 2020;65:906\u201312.","journal-title":"Acta Parasitol"}],"container-title":["Tropical Medicine and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-024-00676-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41182-024-00676-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-024-00676-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T19:45:51Z","timestamp":1736883951000},"score":1,"resource":{"primary":{"URL":"https:\/\/tropmedhealth.biomedcentral.com\/articles\/10.1186\/s41182-024-00676-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["676"],"URL":"https:\/\/doi.org\/10.1186\/s41182-024-00676-3","relation":{},"ISSN":["1349-4147"],"issn-type":[{"value":"1349-4147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"17 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee of Arak University of Medical Science, Arak, Iran (IR.ARAKMU.REC.1396.256).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}